First Indian study to correlate dose of Moxonidine and incidence of dry mouth in patients with chronic kidney disease

Journal Title: World Journal of Pharmaceutical Sciences - Year 2017, Vol 5, Issue 7

Abstract

The sympathetic nervous system is known to play a central role in the pathophysiology of hypertension in CKD patients. A centrally acting sympatholytic drug would not only help reduce blood pressure but also intervene in multiple disease processes. Moxonidine differs from other available centrally acting antihypertensive by exhibiting only low affinity to central α2-adrenoceptors compared to I1-imidazoline receptors. The aim of the study was to evaluate whether moxonidine would result in dry mouth in patients of chronic kidney disease (CKD) and evaluate the presence of a dose dependent response. 55 adult hypertensive patients with CKD were included in the study. The patients were treated with moxonidine at different doses (0.2 mg/day 0.3 mg/day, 0.4 mg per day, 0.6 mg day and 0.9 mg/day) depending on the serum creatinine and eGFR. The highest incidence of dry mouth with moxonidine occurs at the dose of 0.4 mg and a ceiling effect is observed regarding the prevalence of dry mouth at doses above 0.4 mg.

Authors and Affiliations

Vikash Khandelia

Keywords

Related Articles

Antimicrobial studies on Coldenia procumbens Linn. whole plant

The ethanolic extract was screened for growth inhibition of microbes such as Aeromonas hydrophila, Bacillus cereus, Bacillus subtilis, Enterobacter aerogens, Escherichia coli, Klebsiela pneumoniae, Proteus vulgaris, Pseu...

Synthesis, Characterization, Antimicrobial and Antioxidant Activity of 2-Hydroxy-3-Methoxybenzaldehyde-4-Phenylthiosemicarbazone and its Pd(II) Complex, Ni(II) Mixed Ligand Complex and Cu (II) Complex having Heterocyclic Bases

The New four complexes of Pd(II), [Ni(II)dppm], [Cu(II)bipyridyl] and [Cu(II)phenanthroline] were synthesized with 2-hydroxy-3-methoxybenzaldehyde-4-phenylthiosemicarbazone HMBPTSC (L). The FT-IR spectral data indicated...

Comparative clinical evaluation of Shriphaladi Yog & Kukshi Vasti in the management of irritable bowel syndrome

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder in which abdominal pain is associated with defecation or a change in bowel habit. Psychological and somatic management is also desirable in IBS due to...

Medicinal plants with antidiabetic activity - A review of herbal medicine

Diabetes mellitus is one of the most common non-communicable diseases globally. It is the fourth leading causes of death in the most developed countries and there in substantial evendiced that it in epidemic in many deve...

Chemical Constituents from Senecio bombayensis

Plants belonging to the family Asteraceae and the genus Senecio were reported to contain varied compounds with medicinal importance. Senecio bombayensis, a species of Senecio was not studied chemically and hence the auth...

Download PDF file
  • EP ID EP330286
  • DOI -
  • Views 86
  • Downloads 0

How To Cite

Vikash Khandelia (2017). First Indian study to correlate dose of Moxonidine and incidence of dry mouth in patients with chronic kidney disease. World Journal of Pharmaceutical Sciences, 5(7), 39-43. https://europub.co.uk./articles/-A-330286